McKesson Net Profit Margin 2010-2023 | MCK

Current and historical net profit margin for McKesson (MCK) from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue. McKesson net profit margin for the three months ending December 31, 2023 was .
McKesson Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2023-12-31 $301.51B $3.00B 0.99%
2023-09-30 $291.10B $3.49B 1.20%
2023-06-30 $284.04B $3.75B 1.32%
2023-03-31 $276.71B $3.56B 1.29%
2022-12-31 $273.90B $3.14B 1.15%
2022-09-30 $272.03B $2.06B 0.76%
2022-06-30 $268.45B $1.40B 0.52%
2022-03-31 $263.97B $1.11B 0.42%
2021-12-31 $257.01B $1.41B 0.55%
2021-09-30 $250.99B $-4.81B -1.92%
2021-06-30 $245.22B $-4.50B -1.83%
2021-03-31 $238.23B $-4.54B -1.91%
2020-12-31 $237.62B $-4.18B -1.76%
2020-09-30 $234.19B $2.23B 0.95%
2020-06-30 $231.00B $0.92B 0.40%
2020-03-31 $231.05B $0.90B 0.39%
2019-12-31 $224.95B $-0.92B -0.41%
2019-09-30 $221.98B $-0.63B -0.29%
2019-06-30 $217.44B $0.60B 0.27%
2019-03-31 $214.32B $0.03B 0.02%
2018-12-31 $213.52B $-0.32B -0.15%
2018-09-30 $210.93B $0.12B 0.06%
2018-06-30 $209.91B $-0.38B -0.18%
2018-03-31 $208.36B $0.07B 0.03%
2017-12-31 $205.44B $4.80B 2.34%
2017-09-30 $201.96B $4.53B 2.24%
2017-06-30 $199.85B $4.84B 2.42%
2017-03-31 $198.53B $5.07B 2.55%
2016-12-31 $196.50B $1.91B 0.97%
2016-09-30 $194.27B $1.91B 0.99%
2016-06-30 $193.07B $2.22B 1.15%
2016-03-31 $190.88B $2.26B 1.18%
2015-12-31 $189.13B $1.96B 1.04%
2015-09-30 $187.72B $1.80B 0.96%
2015-06-30 $183.12B $1.65B 0.90%
2015-03-31 $179.05B $1.48B 0.82%
2014-12-31 $171.95B $1.71B 1.00%
2014-09-30 $159.80B $1.31B 0.82%
2014-06-30 $148.63B $1.24B 0.84%
2014-03-31 $137.39B $1.26B 0.92%
2013-12-31 $130.20B $1.15B 0.88%
2013-09-30 $126.97B $1.39B 1.09%
2013-06-30 $123.74B $1.38B 1.12%
2013-03-31 $122.20B $1.34B 1.09%
2012-12-31 $122.84B $1.60B 1.30%
2012-09-30 $122.58B $1.60B 1.31%
2012-06-30 $123.04B $1.50B 1.22%
2012-03-31 $122.32B $1.40B 1.15%
2011-12-31 $119.89B $1.30B 1.09%
2011-09-30 $117.30B $1.16B 0.99%
2011-06-30 $114.61B $1.19B 1.04%
2011-03-31 $112.08B $1.20B 1.07%
2010-12-31 $109.87B $1.13B 1.03%
2010-09-30 $109.90B $1.30B 1.18%
2010-06-30 $109.50B $1.27B 1.16%
2010-03-31 $108.70B $1.26B 1.16%
2009-12-31 $108.28B $1.20B 1.10%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $73.380B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $68.292B 19.32
West Pharmaceutical Services (WST) United States $25.906B 46.43
Cardinal Health (CAH) United States $24.133B 13.80
Align Technology (ALGN) United States $20.439B 39.46
Cooper (COO) United States $19.341B 29.27
Labcorp (LH) United States $17.753B 15.28
Henry Schein (HSIC) United States $9.553B 16.99
DENTSPLY SIRONA (XRAY) United States $5.872B 15.20
Merit Medical Systems (MMSI) United States $4.758B 26.08
Patterson (PDCO) United States $2.308B 11.06
CONMED (CNMD) United States $2.301B 20.87
STAAR Surgical (STAA) United States $2.098B 80.57
Atrion (ATRI) United States $0.819B 43.73
Lifevantage (LFVN) United States $0.086B 11.11
Pro-Dex (PDEX) United States $0.067B 33.62
Biolase (BIOL) United States $0.005B 0.00